GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source Last Updated
PSICQUIC March 30, 2022
Displaying entries 3801 - 3825 of 4050 in total
Antibody ▼ Patient Onset (days) Symptom GlyTouCan ID Arbitrary Fluorescence Units (AFU)
IgA Patient 3 4 mild
G12200GB
1965
IgA Patient 3 4 mild
G14569AR
2901
IgA Patient 3 4 mild
G14844CX
374
IgA Patient 3 4 mild
G14988WV
527
IgA Patient 3 4 mild
G15209MJ
418
IgA Patient 3 4 mild
G15407YE
1348
IgA Patient 3 4 mild
G16579HJ
717
IgA Patient 3 4 mild
G17140UR
469
IgA Patient 3 4 mild
G17266GE
524
IgA Patient 3 4 mild
G17390SF
367
IgA Patient 3 4 mild
G17689EW
2358
IgA Patient 3 4 mild
G18057VI
449
IgA Patient 3 4 mild
G19118WX
3902
IgA Patient 3 4 mild
G19868AX
393
IgA Patient 3 4 mild
G21290RB
525
IgA Patient 3 4 mild
G21320TF
458
IgA Patient 3 4 mild
G21460SG
506
IgA Patient 3 4 mild
G21675ZL
495
IgA Patient 3 4 mild
G22768VO
461
IgA Patient 3 4 mild
G24432YB
413
IgA Patient 3 4 mild
G24617OK
3765
IgA Patient 3 4 mild
G25407RZ
398
IgA Patient 3 4 mild
G25473LQ
416
IgA Patient 3 4 mild
G25559RS
1127
IgA Patient 3 4 mild
G26125KY
2601

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024